LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

Search

Orthofix International NV

Fermé

SecteurSoins de santé

13.48 1.66

Résumé

Variation du prix de l'action

24h

Actuel

Min

12.95

Max

13.5

Chiffres clés

By Trading Economics

Revenu

-8.7M

-23M

Ventes

2.5M

206M

BPA

0.198

Marge bénéficiaire

-11.085

Employés

1,616

EBITDA

-11M

-3.1M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+45.48% upside

Dividendes

By Dow Jones

Prochains Résultats

24 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-117M

517M

Ouverture précédente

11.82

Clôture précédente

13.48

Sentiment de l'Actualité

By Acuity

50%

50%

149 / 352 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Weak Bearish Evidence

Orthofix International NV Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

11 févr. 2026, 23:47 UTC

Actions en Tendance

Stocks to Watch: AppLovin, Cisco, Cognex, Pilgrim's Pride

11 févr. 2026, 22:59 UTC

Résultats
Acquisitions, Fusions, Rachats

Grab Holdings to Buy U.S.-Based Stash Financial

11 févr. 2026, 23:54 UTC

Résultats

McDonald's Says Its Value Campaign Is Paying Off -- 2nd Update

11 févr. 2026, 23:50 UTC

Market Talk

Global Equities Roundup: Market Talk

11 févr. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Takaichi's Economic Steps -- Market Talk

11 févr. 2026, 23:49 UTC

Résultats

Singtel: Key Focus Areas Are Strengthening Core Businesses, Scaling Growth Engines, Building Momentum Across Regional Associates >Z74.SG

11 févr. 2026, 23:45 UTC

Résultats

Singtel: Net Exceptional Gain of S$1.15B in 3Q Primarily From Sale of Partial Stake in Bharti Airtel>Z74.SG

11 févr. 2026, 23:42 UTC

Résultats

Singtel 3Q Underlying Net Profit S$744M Vs. S$680M >Z74.SG

11 févr. 2026, 23:41 UTC

Résultats

Singtel 3Q Net S$1.89B Vs. Net S$1.32B >Z74.SG

11 févr. 2026, 23:40 UTC

Résultats

Singtel 3Q Operating Revenue S$3.66B Vs. S$3.63B >Z74.SG

11 févr. 2026, 23:35 UTC

Market Talk

Gold Falls on Prospects of Long Fed Pause -- Market Talk

11 févr. 2026, 23:18 UTC

Market Talk

AppLovin CEO Looks to Soothe Concerns Over AI, Competition -- Market Talk

11 févr. 2026, 23:14 UTC

Market Talk

RBA Governor Faces Barrage of Questions About Govt Spending -- Market Talk

11 févr. 2026, 22:59 UTC

Résultats

Kakao 2025 Net KRW525.72B Vs. Loss KRW161.87B >035720.SE

11 févr. 2026, 22:59 UTC

Résultats

Kakao 2025 Oper Pft KRW732.04B Vs. Pft KRW460.21B >035720.SE

11 févr. 2026, 22:59 UTC

Résultats

Kakao 2025 Rev KRW8.099T Vs. KRW7.872T >035720.SE

11 févr. 2026, 22:58 UTC

Résultats

Kakao 4Q Net Loss Missed FactSet-Compiled Consensus

11 févr. 2026, 22:57 UTC

Résultats

Kakao 4Q Loss KRW39.30B Vs. Loss KRW395.21B >035720.SE

11 févr. 2026, 22:54 UTC

Résultats

Kakao 4Q Oper Pft KRW203.45B Vs. Pft KRW75.43B >035720.SE

11 févr. 2026, 22:53 UTC

Résultats

Kakao 4Q Rev KRW2.133T Vs. KRW1.957T >035720.SE

11 févr. 2026, 22:47 UTC

Résultats

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11 févr. 2026, 22:47 UTC

Résultats

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11 févr. 2026, 22:23 UTC

Résultats

Grab Holdings Expects to Close Stash Acquisition in 3Q of 2026 >GRAB

11 févr. 2026, 22:22 UTC

Résultats

Grab Holdings to Acquire U.S. Digital Financial Services Company Stash Financial >GRAB

11 févr. 2026, 22:22 UTC

Résultats

Grab Holdings Sees FY26 Adj Ebitda $700M to $720M >GRAB

11 févr. 2026, 22:19 UTC

Résultats

Grab Holdings Sees FY26 Rev $4.04B to $4.10B >GRAB

11 févr. 2026, 22:18 UTC

Résultats

Grab Holdings 4Q Adj Ebitda $148.0M Vs. $97.0M >GRAB

11 févr. 2026, 22:18 UTC

Résultats

Grab Holdings 4Q Net $153.0M Vs. Net $11.0M >GRAB

11 févr. 2026, 22:18 UTC

Résultats

Grab Holdings 4Q Oper Pft $52.0M Vs. $2.0M >GRAB

11 févr. 2026, 22:16 UTC

Résultats

Grab Holdings 4Q Rev $906.0M Vs. $764.0M >GRAB

Comparaison

Variation de prix

Orthofix International NV prévision

Objectif de Prix

By TipRanks

45.48% hausse

Prévisions sur 12 Mois

Moyen 19 USD  45.48%

Haut 24 USD

Bas 14 USD

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

2 ratings

1

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

10.4 / 12.1Support & Résistance

Court Terme

Weak Bearish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

149 / 352Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Orthofix International NV

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
help-icon Live chat